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 Until recently, it was possible to state with some confi -
dence that there was no evidence of cannabis-related 
brain damage in humans. Th ere was some support from 
the animal literature, but few human studies had been 
conducted where the fi ndings could not be explained 
by methodological or other confounding factors. 
Recent evidence for gross morphological, connectiv-
ity and microstructural changes has now emerged that 
warrants further consideration. If cannabis were found 
to alter the structural integrity of the brain, then this 
may assist us to understand the mechanisms by which 
cannabis triggers psychotic symptoms or overt psych-
osis in vulnerable individuals. 
 Evidence from animal studies 
 Cannabinoids, either endogenous or exogenous, pos-
sess both neuroprotective and  neurotoxic proper-
ties (Sarne and Mechoulam,  2005 ; Kano  et al .,  2009 ). 
Cannabinoid-receptor activation induces morpho-
logical changes to neurons, such as inhibition of new 
synapse formation (Kano  et al .,  2009 ), and at crucial 
neurodevelopmental stages (prenatal and adolescent), 
exposure to cannabinoids impacts on neural cell sur-
vival and maturation ( Chapters 6 ,  7 ) (Downer and 
Campbell,  2010 ). Th e role of diff erent cannabinoids in 
controlling neural-cell survival or death is a complex 
issue  that is infl uenced by the dose, duration of expos-
ure and route of administration, but also the neural-
cell type and its stage of diff erentiation (Downer and 
Campbell,  2010 ). Contradictory hypotheses circulate 
regarding the doses of  Δ 9 -tetrahydrocannabinol (THC) 
that may be neurotoxic or neuroprotective. Some sug-
gest that single high doses of THC are neuroprotec-
tive within a limited timeframe, but that low doses are 
neurotoxic and, with chronic exposure, induce neur-
onal death (Sarne and Keren,  2004 ; Tselnicker  et al , 
 2007 ; Sarne and Mechoulam,  2005 ). However, large 
doses of THC applied directly to cultured hippocam-
pal neurons, and both high and low doses to cultured 
cortical neurons, have been shown to cause cell death 
or signifi cant neurotoxic changes (eg. shrinkage of 
cell bodies and DNA-strand breaks) characteristic of 
neuronal apoptosis (Chan  et al .,  1998 ; Campbell,  2001 ; 
Downer  et al .,  2001 ). Indeed, even a single adminis-
tration of an ultra-low dose of THC (0.001–0.002 mg/
kg) has been shown to result in long-term cognitive 
impairment (in spatial learning, strategy and working 
memory) in mice. Th ese defecits persisted for at least 
5 months post-injection and were associated with acti-
vation of extracellular-regulated kinase (ERK) in the 
cerebellum and hippocampus (Tselnicker  et al .,  2007 ; 
Amal  et al .,  2010 ). Th e authors suggested that low THC 
concentration is the main determinant of long-lasting 
neuronal eff ects following chronic exposure to can-
nabinoids, due to their slow clearance and accumula-
tion (Amal  et al .,  2010 ). 
 A study of cannabinoid application in vitro showed 
that THC appears to accumulate primarily in neurons 
and that transformation to its metabolite, THC-COOH, 
depends on the presence of glia (Monnet-Tschudi  et al ., 
 2008 ). Th e authors suggested that the adverse eff ects of 
cannabinoids on the brain may occur through a com-
bination of pathways involving cannabinoid receptor 
activation, accumulation of cannabinoids and their 
metabolites and upregulation of neuroinfl ammatory 
cytokines. Given the dependence on glia for metab-
olism of THC, if white-matter aberrations develop 
in cannabis users (as discussed further below), more 
THC could potentially accumulate in neurons, causing 
toxicity. 
 Studies of chronic cannabinoid administration to 
animals have demonstrated cognitive impairment asso-
ciated with specifi c neurochemical, transmission and cell 
fi ring alterations, particularly in the hippocampus, but 
also the prefrontal cortex (PFC), similar to impairment 
 Does cannabis cause lasting 
brain damage? 
 Nadia Solowij ,  Murat Y ü cel, Valentina Lorenzetti  and  Dan  Lubman 
104
Chapter 9: Does cannabis cause lasting brain damage?
density and decreases in astroglial markers, protein 
expression and N-methyl- d -aspartate receptor levels 
within the hippocampus. Th us, adolescent exposure to 
THC resulted in long-lasting alterations to the struc-
tural and functional plasticity of both neurons and glia, 
with a reduction in synaptic contacts and/or less effi  -
cient synaptic connections throughout the hippocam-
pus. In  other studies, these authors found signifi cant 
gender-related THC neurotoxic eff ects, demonstrating 
that CB1 receptor density and G-protein coupling were 
signifi cantly reduced in the amygdala, ventral tegmental 
area and nucleus accumbens in female rats, but only in 
the amygdala and hippocampus of male rats, accompan-
ied by diff erent behavioral profi les (Rubino  et al .,  2008 ). 
Further, spatial working memory impairment was  simi-
lar between genders but was underpinned by hippocam-
pal alterations in males, in contrast to PFC alterations 
in females (Rubino  et al .,  2009b ). Th is work supports 
a growing literature demonstrating sex diff erences in 
adulthood in animals chronically administered THC 
during adolescence, as well as alterations within circuits 
underlying emotional processing (Realini  et al .,  2009 ). 
 Th ere is also growing evidence of diff erential 
responses to cannabis during adolescence com-
pared with adulthood. Quinn  et al . ( 2008 ) found that 
repeated exposure to THC was less behaviorally aver-
sive for adolescent compared with adult rats, but caused 
greater persistent memory defi cits and hippocampal 
structural and functional alterations. Altered protein 
expression in the hippocampus was observed in both 
adult and adolescent rats, but adolescent rats showed 
a greater number of altered proteins related to oxida-
tive stress, mitochondrial and metabolic function, cell 
proliferation and repair, and cytoskeletal structure 
and signaling. Further recent research on neurotrans-
mitter system functionality and cannabinoid receptor 
changes following chronic exposure to cannabinoids 
suggests that the adolescent brain does not compen-
sate for the biological changes in response to cannabis 
exposure in the same way as the adult brain (Dalton 
and Zavitsanou,  2010 ; Zavitsanou  et al .,  2010 ). Th e ECS 
also appears to be altered by exposure to  THC during 
early, middle and late adolescence (Ellgren  et al .,  2008 ). 
In a rat study, intermittent exposure to THC (a pattern 
of use common among teenagers) was found to reverse 
the normal proportional ratio of eCBs (anandamide 
and 2-arachidonoyl glycerol [2-AG] ) in the PFC and 
nucleus accumbens. Th ese studies support the notion 
that THC eff ects on neural integrity may depend on 
diff erent developmental stages of exposure. 
induced by lesions or transient inactivation (Egerton 
 et al .,  2006 ). Chronic administration of THC to rats and 
primates has been shown to result in dose-dependent 
neurotoxic changes in brain regions that are rich in can-
nabinoid receptors. Specifi cally,  THC-induced neuro-
toxic eff ects are prominent within the hippocampus 
(Heath  et al .,  1980 ; Scallet  et al .,  1987 ; Landfi eld  et al ., 
 1988 ; Chan  et al .,  1998 ; Lawston  et al .,  2000 ), amyg-
dala (Heath  et al .,  1980 ), septum (Harper  et al .,  1977 ; 
Myers and Heath.,  1979 ) and cerebral cortex (Harper 
 et al .,  1977 ; Downer  et al .,  2001 ). Th ese neurotoxic 
eff ects include shrinkage of neural cell nuclei and bodies 
(Heath  et al .,  1980 ; Scallet  et al .,  1987 ) and reductions in 
pyramidal cell density (Lawston  et al .,  2000 ), dendritic 
length (Landfi eld  et al .,  1988 ) and number of synapses 
(Heath  et al .,  1980 ). Some of these studies have emulated 
chronic-use patterns seen in humans: for example, in 
the study by Landfi eld and colleagues ( 1988 ) THC was 
administered to rats fi ve times a week for 8 months, rep-
resenting approximately 30% of the rats’ lifespan. 
 Cannabis use in humans typically commences 
during adolescence and young adulthood, a cru-
cial period of neurodevelopment (see  Chapter 7 ). 
Neuromaturational changes primarily occur within 
PFC and limbic circuits, and include progressive and 
regressive changes such as myelination and synaptic 
pruning, neurogenesis and apoptosis, axonal growth 
and sprouting, dendritic arborization and retraction, 
synaptogenesis and synapse elimination, alongside 
the maturation of multiple neurotransmitter systems 
(Schneider,  2008 ; Realini  et al .,  2009 ). Th e endocan-
nabinoid (eCB) system (ECS) is crucially involved in 
these developmental processes (Harkany  et al .,  2008 ; 
Schneider,  2008 ; Realini  et al .,  2009 ) that are thought 
to be essential for the acquisition of adult cognition, 
decision-making and  social behaviors. As such, expos-
ure to THC during adolescence may perturb neu-
rodevelopmental processes with potential long lasting 
consequences. 
 As discussed in detail in  Chapter 7 , a number of 
studies have examined the impact of THC admin-
istration during  adolescence on the adult brain. For 
instance, Rubino and colleagues ( 2009a ) administered 
THC twice daily to adolescent rats for 10 days and then 
left  them undisturbed until adulthood, at which point 
they assessed learning and memory capacities, as well 
as their underlying neural substrates. Defi cits in spa-
tial memory were evident in the pretreated rats and 
were accompanied by, and correlated with, signifi cantly 
lower total dendritic length and number, reduced spine 
Chapter 9: Does cannabis cause lasting brain damage?
105
demonstrated evidence of structural brain abnormal-
ities, but these were not consistent across studies. 
 Six studies reported specifi c regional structural 
alterations in regular cannabis users (Campbell  et al ., 
 1971 ; Block  et al .,  2000 ; Wilson  et al .,  2000 ; Matochik 
 et al .,  2005 ; Medina  et al .,  2007b ; Y ü cel  et al .,  2008 ), while 
the remaining seven studies found no signifi cant volu-
metric diff erences between users and controls (Stefanis, 
 1976 ; Co  et al .,  1977 ; Kuehnle  et al .,  1977 ; Hannerz 
and Hindmarsh,  1983 ; Jager  et al .,  2007 ; Medina  et al ., 
 2007a ; Tzilos  et al .,  2005 ). Alterations in hippocampal 
or parahippocampal volumes  were the most consist-
ently reported fi ndings, but the nature of the fi ndings 
were still mixed.  Hippocampal volumes in cannabis 
users were found to be smaller (Matochik  et al .,  2005 ; 
Y ü cel  et al .,  2008 ), larger (Medina  et al .,  2007b ), or no 
diff erent to controls (Block  et al .,  2000 ; Wilson  et al ., 
 2000 ; Medina  et al .,  2007a ). Of three studies that exam-
ined parahippocampal volume, two reported no change 
(Jager  et al .,  2007 ; Tzilos  et al .,  2005 ), while one found 
an  alteration in grey and white matter composition 
(Matochik  et al .,  2005 ). Two studies examined amygdala 
volumes, with one reporting reduced volume (Y ü cel 
 et al .,  2008 ) and the other no change (Wilson  et al ., 
 2000 ). Finally, there were a number of brain regions that 
were investigated only within a single study, with sig-
nifi cant between-group diff erences found for the pre-
central gyrus, thalamus, parietal lobule, fusiform gyrus, 
lentiform nucleus and pons (Matochik  et al .,  2005 ), but 
not for the cerebellum (Block  et al .,  2000 ). While few 
studies have specifi cally examined white-matter vol-
ume, we recently identifi ed signifi cant cerebellar white 
matter reduction in adult long-term very heavy canna-
bis users (Solowij  et al .,  2011 ). 
 Dose and duration of cannabis exposure may dif-
ferentiate between those studies that did or did not fi nd 
volumetric diff erences between users and controls. For 
example, in our study (Y ü cel  et al .,  2008 ) the cannabis 
users had a similar exposure to that of Landfi eld  et al .’s 
( 1988 ) rodent study (cited above). Both of these studies 
found signifi cant dose-related reductions in hippoc-
ampal volume. Th e  cannabis users within our study had 
the most extensive exposure to cannabis of all the stud-
ies of human cannabis users (near daily use for a mean 
19.7 years, range 10–32 years), and the most striking 
fi ndings. We reported a 12% reduction bilaterally in 
hippocampal volumes, as well as an approximate 7% 
reduction in bilateral amygdala volumes (Y ü cel  et al ., 
 2008 ), and a 24% reduction in cerebellar white matter 
(Solowij  et al .,  2011 ). Th e reduction of left  hippocampal 
 Th us, evidence from preclinical research has iden-
tifi ed neurotoxic, morphological and microstructural 
alterations to the brain in vitro and, when animals are 
acutely or chronically exposed to cannabinoids, at 
doses relevant to human use. With discrepant results 
concerning the neurotoxicity of low and high doses, 
and accumulation of cannabinoids, further research 
must reconcile dose-eff ects in vitro versus in vivo, and 
consider the various cannabinoids that human users 
expose themselves to. Some of these have been shown 
to have diff erential properties and opposing eff ects in 
humans (eg. THC versus cannabidiol; see  Chapter 1 ). 
As such, animal research could examine each of these 
in isolation and in combination, and further elucidate 
their impact on the developing brain. 
 Evidence from human studies 
 Adult chronic cannabis users 
 Findings of persistent alteration of brain function or 
cognitive impairment in human  cannabis users (as 
reviewed in  Chapter 8 ), together with the animal work 
discussed above, support the notion that long-term 
cannabis use may result in morphological alterations 
of brain structures that subserve attention, learning, 
memory, executive functions and emotional processes 
(such as the prefrontal and temporal cortices). To date, 
fi ndings from structural neuroimaging studies of long-
term cannabis users have been contradictory, with 
evidence for both the presence and absence of morpho-
logical changes in specifi c brain regions (DeLisi,  2008 ; 
Solowij  et al .,  2009 ; Lorenzetti  et al .,  2010 ; Martin-
Santos  et al .,  2010 ). However, a number of variables, 
such as demographic, clinical, genetic and drug-use 
factors are likely to mediate the relationship between 
cannabis use and brain structural alterations. 
 A recent review (Lorenzetti  et al .,  2010 ) identifi ed 
only 13 structural  neuroimaging studies where the pri-
mary substance used was cannabis and major psycho-
pathologies were excluded. Th e main imaging modality 
utilized was magnetic resonance imaging (MRI) (eight 
studies), with three studies employing computed 
tomography (CT) and two early studies using pneu-
mo-encephalography and echo-encephalography, 
respectively. Th e MRI studies used either a region-of-
interest  approach (six studies) or voxel-based morph-
ometry (VBM; two studies). No signifi cant diff erences 
were found in any of the studies on global measures 
of brain volume. More specifi c regional brain analyses 
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 Several recent studies have examined the integ-
rity of white matter fi ber tracts in cannabis users using 
diff usion tensor imaging (DTI), including studies of 
adolescent users (reported below). A pilot study in 
ten heavy cannabis users demonstrated trends toward 
both increased mean diff usivity and lower fractional 
anisotropy in the anterior cingulate cortex (Gruber 
and Yurgelun-Todd,  2005 ). Another study of heavy 
users found signifi cantly increased mean diff usivity in 
the anterior region of the corpus callosum, where white 
matter passes between the prefrontal lobes (Arnone 
 et al .,  2008 ).  Th e data suggest impaired structural integ-
rity of the corpus callosum fi ber tracts with prolonged 
cannabis exposure, particularly as the authors reported 
an association with duration of cannabis use within the 
sample. White matter tractography investigations in 
cannabis users are only at a preliminary stage of inves-
tigation and hold much promise for the future. 
 A post-mortem study of cannabinoid recep-
tor density and integrity in human brains found that 
the receptor becomes hypofunctional with chronic 
cannabis use (Villares,  2007 ). Downregulation was 
observed in the hippocampus, basal ganglia and mes-
encephalon of chronic users, and reduced binding lev-
els were accompanied by parallel decreases in mRNA 
levels. Th ese fi ndings suggest that the primary eff ect of 
chronic exposure was on the CB1 receptor gene rather 
than on the receptor protein. Evidence of diminished 
neuronal and axonal integrity in the dorsolateral pre-
frontal cortex has been indicated by magnetic reson-
ance spectroscopic markers of metabolism (NAA/tCr 
ratio) (Hermann  et al .,  2007 ). Dose-related changes in 
this study were also found in the anterior cingulate and 
putamen/globus pallidum, but not in the hippocampus. 
Acute and chronic exposure to cannabis in humans has 
also been associated with reduced serum concentra-
tions of neurotrophins, including nerve growth factor 
(Angelucci  et al .,  2008 ) and brain derived neurotrophic 
factor (BDNF) (D’Souza  et al .,  2009 ). 
 Th us, there is growing evidence for alterations to 
the structural integrity of the brain as a result of chronic 
cannabis exposure in adult users. Th is includes gross 
structural anatomical studies of long term and heavy 
users, as well as more refi ned studies of white matter 
and connectivity, and neurotoxic markers in vivo. 
 Adolescent and young-adult cannabis users 
 An increasing number of studies have investigated 
brain morphology in adolescent  cannabis users or in 
adults who started using cannabis at a young age. A 
volume was of a similar magnitude to that observed in 
schizophrenia, was dose-related and was associated 
with subclinical psychotic symptoms, even though our 
sample was carefully screened for DSM-IV psychotic 
disorders. 
 One other study with a similar mean duration of 
use (mean 22.6 years, range 12–33 years) to the sam-
ple in our study, reported no brain alterations, but the 
minimum duration of  daily use in that sample was only 
one year (Tzilos  et al .,  2005 ). In contrast, the minimum 
duration of  near daily use in our study was 10 years. A 
further key diff erence between the Tzilos  et al . ( 2005 ) 
study and ours was in the estimated episodes of use, 
and hence the cumulative dose of exposure to cannabis. 
Tzilos  et al .’s sample reported an average of 20 100 life-
time episodes of use. Our sample had an average 62 000 
estimated episodes of use over the lifetime. Th us, des-
pite a similar mean duration of use, our cannabis users 
used more than three times as much cannabis, which 
may be the crucial factor in explaining our fi nding of a 
dose–response relationship between hippocampal vol-
ume and cumulative cannabis use. In addition, Tzilos 
 et al . . ( 2005 ) acquired their images at a lower fi eld 
strength and with a coarser spatial resolution (1.5 T 
with 3-mm-thick slices vs. 3 T with 1-mm-thick slices 
in our study), an important consideration given the 
small size and boundary defi nition of the brain struc-
tures investigated. Moreover, the region of interest 
measured in their study was less specifi c to the hippo-
campus relative to ours because they also included the 
parahippocampal gyrus (ours was restricted to the 
hippocampus itself using well-defi ned boundaries). 
 A general trend for an inverse relationship between 
indices of cannabis use and hippocampal or parahip-
pocampal volume appears to exist in other studies. 
Aside from our own study, samples with greater canna-
bis exposure demonstrated reductions in hippocampal 
or parahippocampal volumes (Matochik  et al .,  2005 ), 
whereas samples with a lower quantity or frequency of 
cannabis use exhibited no change (Block  et al .,  2000 ; 
Wilson  et al .,  2000 ; Jager  et al .,  2007 ; Medina  et al ., 
 2007a ; Tzilos  et al .,  2005 ), or even volumetric increases 
(Medina  et al .  2007b ). Studies of heavy cannabis users 
(Matochik  et al .,  2005 ; Y ü cel  et al .,  2008 ) were more 
likely to detect regional abnormalities than those of 
lighter cannabis users. Greater brain alterations with an 
earlier age of onset of cannabis use have been reported 
in some studies (Wilson  et al .,  2000 ), but not others 
(Matochik  et al .,  2005 ; Tzilos  et al .,  2005 ), but this aspect 
of human cannabis use remains underinvestigated. 
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adolescents was associated with poor performance in 
attention, working memory and speed of processing 
tasks (Bava  et al .,  2010 ). Higher integrity of white mat-
ter fi ber tracts in the cannabis users relative to controls 
(interpreted as a neurodevelopmental compensatory 
mechanism in response to exposure to cannabis) was 
associated with better performance, except for in one 
anterior region where higher integrity was associated 
with poorer contextual verbal memory performance. 
Th e interactive eff ects of cannabis and alcohol should 
be further investigated, particularly as they are fre-
quently used together by adolescents. 
 Altered cortical gyrifi cation in the frontal lobe 
and abnormal age-related changes to gyrifi cation and 
cortical thickness have also recently been reported in 
adolescent and young adult users (Mata  et al .,  2010 ). 
Cannabis users showed  bilaterally decreased concavity 
of the sulci (i.e. greater fl attening) in frontal, temporal 
and parietal lobes, and thinner sulci in the right frontal 
lobe, in the absence of global brain structural diff erences 
between users and controls. Abnormal cortical gyrifi ca-
tion may refl ect abnormal neurodevelopment or neu-
rodegeneration. A lack of normal  association between 
these measures and increasing age in the cannabis users, 
together with a lack of observed associations with spe-
cifi c cannabis-use parameters led the authors to specu-
late that cannabis use during adolescence or young 
adulthood might prematurely alter cortical gyrifi cation 
toward patterns usually seen at a later age. 
 Further specifi c investigations of brain structure 
and function are clearly warranted in adolescent can-
nabis-using samples to verify whether cannabis has 
specifi c and/or more detrimental eff ects than in adult 
users; whether there are age-of-onset-dependent and 
gender eff ects; and whether there is a progression of 
brain morphological abnormalities with continued 
cannabis use, or reversal with abstinence. 
 Patients with psychosis 
 Since brain structural changes are evident in patients 
with schizophrenia, and there is mounting evidence for 
similar changes in association with heavy cannabis use, 
it is  possible that cannabis may exert greater adverse 
eff ects on brain morphology when the brain is already 
compromised. Indeed, this is most likely to occur in 
brain regions known to be altered in both heavy canna-
bis users and patients with schizophrenia (e.g., hippo-
campus). In line with this, a number of recent studies 
have investigated brain morphology in patients with 
study of adult users reported that early onset cannabis 
users (before age 17 years) had smaller whole brain vol-
umes, lower percent cortical grey matter, higher per-
cent white matter and increased cerebral blood fl ow 
compared with later onset users (Wilson  et al .,  2000 ). 
 Th e two studies by Medina and colleagues discussed 
above were of adolescents, one reporting larger hippoc-
ampal volumes in users (Medina  et al .,  2007b ), while the 
other found no volumetric diff erences from controls 
(Medina  et al .,  2007a ). Medina  et al . ( 2007a ) also found 
an association between whole brain white matter vol-
ume and depressive symptoms in young adult cannabis 
 users. While a DTI study of young adults who had at least 
one year of daily or several times/week cannabis during 
adolescence, found no evidence of pathological white 
matter integrity diff erences between users and con-
trols, it identifi ed several  regions of apparently greater 
integrity among users (DeLisi  et al .,  2006 ). However, a 
solid body of evidence for pathology in white matter 
tracts within the corpus callosum and various fronto-
temporal, occipito-frontal and posterior connections 
that develop during adolescence, has come from other 
recent DTI studies of young adult (Arnone  et al .,  2008 ; 
Allin  et al .,  2009 ) and adolescent (Ashtari  et al .,  2009 ; 
Bava  et al .,  2009 ; Y ü cel  et al .,  2011 ) cannabis users, as 
well as adolescents with substance use disorders (pri-
marily cannabis) (Th atcher  et al .,  2010 ). Abnormalities 
in this latter study were greater in females than in males. 
Th e results from these studies overall suggest that can-
nabis use, particularly during adolescence, may aff ect 
the trajectory of normal brain maturation resulting in 
white matter aberrations, which may underlie compro-
mised cognitive processing and may even underpin the 
propensity for cannabis to cause psychosis (Allin  et al ., 
 2009 ; Solowij  et al .,  2011 ). 
 Interestingly, Jacobus  et al . ( 2009 ) reported greater 
white matter integrity alterations in several brain 
regions in adolescent binge drinkers than in adolescent 
heavy cannabis users who were also binge drinkers. Th e 
latter group diff ered from controls in three regions, 
while alcohol only users diff ered in eight regions. Th e 
data suggest subtle white-matter-tissue microstruc-
tural abnormalities refl ecting poor tract  coherence 
and organization, but not tissue loss or demyelin-
ation, and imply interactive eff ects of cannabis and 
alcohol or a possible neuroprotective role of cannabis 
in binge drinking . In a further investigation of cogni-
tive function in relation to white matter integrity, these 
same authors found that reduced white matter integ-
rity in temporal regions in cannabis and alcohol using 
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of psychosis, but there are limited data to support these 
notions. Th e interrelationships between cognition and 
psychopathology, and indeed between brain structure 
and function, are complex. 
 Few structural brain imaging studies of canna-
bis users have specifi cally examined the relationship 
between brain volumes and cognitive performance 
measures and most of those that did found no asso-
ciations (Tzilos  et al .,  2005 ; Jager  et al .,  2007 ; Medina 
 et al .,  2007b ; Y ü cel  et al .,  2008 ) or isolated relationships 
(Medina  et al .,  2007a ; Solowij  et al .,  2008 ). An exception 
to this was the fi nding of poor white-matter structural 
integrity being related to poorer cognitive perform-
ance in cannabis and alcohol-using adolescents (Bava 
 et al .,  2010 ). Th e lack of association in most studies 
might be interpreted as aberrant associations between 
brain structure and function, as discussed elsewhere 
(Solowij  et al .,  2009 ). 
 Th e growing literature reporting an association 
between cannabis use and the development of psycho-
pathology, including both psychotic and depressive 
symptoms, has searched for mediators of risk such as 
genes (eg.  COMT ; Caspi  et al .,  2005 ), but associations 
between the development of psychotic or depressive 
symptoms and brain changes in cannabis users have 
not been rigorously investigated. We reported an asso-
ciation between smaller left  hippocampal volume in 
cannabis users and subclinical positive psychotic symp-
toms as measured by the Scale for the Assessment of 
Positive Symptoms (SAPS) (Y ü cel  et al .,  2008 ). Positive 
symptom scores were also correlated with cumulative 
cannabis exposure. Th e cannabis users in our sam-
ple were carefully screened for DSM-IV Psychotic 
Disorders, had never been diagnosed with Major 
Depressive Disorder and had never sought treatment 
for any psychological disorders. Yet the majority of the 
sample endorsed beliefs (scores on  the SAPS ranged 
from Questionable to Mild) concerning ideas of per-
secution, reference, mind reading, sin and/or guilt, 
while some displayed bizarre clothing/appearance or 
reported bizarre social/sexual behavior. Smaller left  
hippocampal volume was also signifi cantly correlated 
with higher scores on the paranoid subscale of the Brief 
Symptom Inventory (BSI) (unpublished data). Negative 
symptoms were elevated in the cannabis users but 
were unrelated to hippocampal volumes. Depressive 
symptoms, which were also elevated, did not correl-
ate with volumetric measures of any brain region, and 
the relationship between left  hippocampal volume and 
cumulative exposure to cannabis remained signifi cant 
schizophrenia or early psychosis and comorbid canna-
bis use. 
 No diff erences in brain structure between patients 
with established schizophrenia who did and did not 
use cannabis were reported by Cahn  et al . ( 2004 ), while 
Potvin  et al . ( 2007 ) found increased striatal grey mat-
ter densities in schizophrenia patients with comorbid 
substance-use disorders (primarily cannabis). In 
fi rst-episode psychosis patients who use cannabis, 
decreased grey matter volumes of the anterior cin-
gulate (Szeszko  et al .,  2007 ), right posterior cingulate 
cortex and left  hippocampus (Bangalore  et al .,  2008 ) 
were reported relative to their non-using counterparts 
and to healthy controls. Trends toward smaller left  and 
right cerebellar volumes were also apparent (Bangalore 
 et al .,  2008 ). Rais and colleagues ( 2008 ) reported 
greater lateral and third ventricle enlargements and 
more pronounced total cerebral grey matter volume 
reduction over 5 years in fi rst- episode schizophrenia 
patients who used cannabis compared with those who 
did not, as well as in comparison with healthy controls 
(2.67% and 5.09% reduction, respectively). Th e results 
were suggested to explain some of the detrimental 
eff ects of cannabis use in patients with schizophrenia. 
We have recently reported hippocampal shape  alter-
ation (Solowij  et al .,  2010 ) and an almost 30% loss of 
cerebellar white matter relative to healthy controls 
in patients with schizophrenia and extensive canna-
bis use histories (Solowij  et al .,  2011 ). Finally, Dekker 
 et al . ( 2010 ) found that the age of onset of cannabis 
use (before age 15 years versus age 17 years or later) 
had no bearing on white matter integrity of the cor-
pus callosum in a sample of young adults with recent 
onset schizophrenia, while cannabis-na ï ve patients 
showed greater abnormalities. Th ese results support 
the notion that cannabis-using patients may represent 
a group who developed psychosis in part at least as a 
consequence of their cannabis use (Dekker  et al .,  2010 ; 
Y ü cel  et al .,  2010 ). Clearly, the impact of cannabis use 
on brain function and structure in schizophrenia also 
warrants further investigation. 
 What might be the implications
 of structural brain changes in 
cannabis users? 
 It is oft en assumed that alterations in the morphology 
of the brain may underlie  impaired cognition and may 
indicate neural substrates of risk for the development 
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(cognitive and mental health) sequelae that resemble 
aspects of schizophrenia. Th ese changes may occur not 
only in individuals who are vulnerable to the devel-
opment of such disorders, but also in nonvulnerable 
individuals if cannabis is used heavily for prolonged 
periods or commences during crucial neurodevelop-
ment periods such as early adolescence. 
 Conclusions 
 Strong evidence for cumulative, sometimes dose-
 related, neuronal damage or microstructural alter-
ations following chronic exposure to cannabinoids 
(largely THC) comes from the animal literature. While 
previous research failed to identify structural brain 
abnormalities in human cannabis users, more recent 
studies using high-resolution imaging techniques, 
combined with more robust delineations of spe-
cifi c brain regions in very heavy cannabis users, have 
revealed evidence of dose-related alterations, mostly in 
the hippocampal and parahippocampal regions. Our 
own fi ndings of signifi cant hippocampal and amygdala 
volume loss in cannabis users suggest potential toxicity 
due to cumulative exposure to large doses of cannabis 
over many years. However, the structural neuroimag-
ing studies of cannabis users have so far focused on a 
narrow range of brain regions. Cannabis use, particu-
larly during early adolescence, may aff ect the morph-
ology of other cortical (e.g. PFC) and subcortical (e.g. 
striatum) brain areas, where cannabinoid receptors are 
heavily concentrated. Hippocampal changes accord 
with hippocampal functional alterations in functional 
imaging studies, which together with evidence of aber-
rations from spectroscopic and DTI studies, impli-
cate the PFC. Evidence for damage to white-matter 
integrity in cannabis users implicates neural circuitry 
across multiple regions. Diff erences in the methods of 
measurement used and the brain regions investigated 
and small sample sizes of varying age and exposure to 
cannabis, may have contributed to the heterogeneity of 
fi ndings across human studies overall. 
 While the evidence is only beginning to accumu-
late from a small number of studies that have used 
rigorous methods to investigate structural brain alter-
ations in cannabis users, it seems that long-term heavy 
cannabis use can result in brain pathophysiological 
and functional changes that resemble aspects of 
schizophrenia. Th e data suggest that such alterations 
are likely to occur when cannabis is used very heavily 
over a prolonged period and typically involve medial 
aft er controlling for depressive symptoms. An associ-
ation between depression and hippocampal volume is 
seen in the more persistent forms of Major Depressive 
Disorder (eg. MacQueen  et al .,  2005 ; Lorenzetti  et al ., 
 2009 ), which does not apply to our sample. One other 
study has reported an association between overall brain 
white-matter volume and depressive symptoms in ado-
lescent/young adult cannabis users without diagnos-
able mood disorders (Medina  et al .,  2007b ). 
 Subclinical positive psychotic symptom scores in 
the heavy cannabis users of our sample correlated with 
spatial span errors, but no other associations between 
cognitive measures and symptoms were observed 
(Solowij  et al .,  2008 ). Skosnik and colleagues ( 2001 , 
 2006 ,  2008 ) have found associations between cognitive 
(eg. poor negative priming) and psychophysiological 
measures (e.g. P300 to aff ective stimuli; 20 Hz neural 
synchrony), and higher scores on the Schizotypal 
Personality Questionnaire , on which cannabis users 
generally obtained high positive-syndrome scores. 
 Acute administration of  THC to healthy volunteers 
and patients with schizophrenia induces both cognitive 
impairment and transient positive and negative symp-
toms ( Chapter 18 ; D’Souza  et al .,  2004 ,  2005 ; Koethe 
 et al .,  2006 ), and sensitivity to the psychosis-inducing 
 and cognitive-impairing eff ects of cannabis may be 
genetically mediated ( Chapter 12 , Henquet  et al .,  2006 ). 
In patients with schizophrenia, associations between 
positive psychotic symptoms and memory defi cits, and 
volumetric measures of the hippocampus, the superior 
temporal gyrus, and the temporal lobe in general, have 
been demonstrated, as well as between negative symp-
toms, executive function and prefrontal cortical meas-
ures (Antonova  et al .,  2005 ; Gur  et al .,  2007 ; Nestor 
 et al .,  2007 ; Hurlemann  et al .,  2008 ) and in particular, 
in relation to white matter structural integrity (Szeszko 
 et al .,  2008 ). Th is suggests that further investigation of 
brain structural changes in cannabis users, in relation 
to symptoms and cognition, is warranted. 
 A crucial question is the extent to which inter-
related structural-functional aberrations involving 
the hippocampus, prefrontal regions or indeed other 
brain structures in cannabis users, might refl ect a vul-
nerability to schizophrenia. Our own fi ndings suggest 
that long-term exposure to cannabis constitutes a vul-
nerability to psychopathology by disrupting the struc-
tural integrity of brain regions that are also involved 
in psychotic (and aff ective) disorders. We propose 
that long-term heavy cannabis use leads to structural 
brain changes and associated deleterious functional 
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temporal lobe structures. Th e cumulative evidence 
for neurocognitive dysfunction similar to that seen 
in schizophrenia and the development of subclinical 
psychotic symptoms in cannabis users, combines with 
the limited data from structural neuroimaging stud-
ies to support our proposition that chronic cannabis 
use may result in schizophrenia-like changes in brain 
structure and function. Th is is further supported by 
evidence that long-term exposure to cannabis may 
result in lasting dysfunction of the endogenous canna-
binoid system, as well as alterations in the functional-
ity of a number of neurotransmitter systems – changes 
that resemble schizophrenia-like conditions in the 
brain (see Solowij  et al .,  2009 ). Th ere may be mul-
tiple moderators or mediators of adverse sequelae 
from long-term heavy cannabis use, including gen-
etic variation, gender, environmental factors and early 
neurodevelopmental insults and stress, that interact 
with cumulative exposure to high-dose cannabis use 
to produce schizophrenia-like sequelae. A crucial fac-
tor is in determining the parameters of cannabis use 
that lead to these structural and functional alterations 
in individuals who are, compared with those who are 
not, at high risk for the development of neuropsychi-
atric disorders, at various neurodevelopmental peri-
ods, and identifying the protective mechanisms that 
prevent the onset of such potentially devastating 
disorders. 
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